Train-of-four Monitoring Using the Tetragraph
1 other identifier
interventional
100
1 country
1
Brief Summary
This is a prospective study that will evaluate the feasibility of using the Tetragraph Neuromuscular Transmission Monitor in comparison to standard (visual) train-of-four assessment with a peripheral nerve stimulator in pediatric patients undergoing surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable surgery
Started Feb 2021
Typical duration for not_applicable surgery
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2020
CompletedFirst Posted
Study publicly available on registry
July 17, 2020
CompletedStudy Start
First participant enrolled
February 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2023
CompletedResults Posted
Study results publicly available
August 12, 2024
CompletedAugust 12, 2024
August 1, 2024
2.3 years
July 13, 2020
June 21, 2024
August 7, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Baseline TOFr (%)
Train of four (TOF) is measured by giving 4 quick electrical pulses to the muscle and counting the number of muscle twitches. Baseline TOFr is the ratio between the fourth twitch of the train of four (TOF) sequence (T4) and the first (T1) prior to administration of the neuromuscular blocking agent and then multiplied by 100 to get a percentage. A lower TOFr equals stronger neuromuscular block and more muscle paralysis.
Immediately prior to start of surgery
Recovered TOFr (%)
Train of four (TOF) is measured by giving 4 quick electrical pulses to the muscle and counting the number of muscle twitches. Recovered TOFr is the ratio between the fourth twitch of the train of four (TOF) sequence (T4) and the first (T1) after recovery from the neuromuscular blocking agent and then multiplied by 100 to get a percentage. A TOFr greater than or equal to 90% indicates adequate recovery from the neuromuscular block.
At the end of surgery (maximum 7 hours from baseline)
Secondary Outcomes (3)
Baseline Amplitude (mV)
Immediately prior to start of surgery
Recovered Amplitude (mV)
At the end of surgery (maximum 7 hours from baseline)
Rate of Muscle Recovery (Minutes)
At the end of surgery (maximum 7 hours from baseline)
Study Arms (1)
Tetragraph
EXPERIMENTALInterventions
TetraGraph is a unique, EMG-based portable device for quantitative (objective) monitoring of neuromuscular function. It is a precise and easy to use tool for monitoring depth of block, ensuring adequate recovery of muscle function, and aiding the clinician to reduce the incidence of residual block.
Eligibility Criteria
You may qualify if:
- Pediatric patients requiring anesthetic care and use of neuromuscular blockade
- Weight range of 20 - 60 kg
You may not qualify if:
- Patients with history of a peripheral neurologic or neuropathic disorder
- Patients in whom the upper extremity cannot be used for TOF monitoring
- Patients undergoing a surgical procedure in which neuromuscular blockade is not required
- Edematous patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Joseph D. Tobiaslead
Study Sites (1)
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
Related Publications (1)
Tobias JD, Epstein RH, Rice-Weimer J, Yemele Kitio SA, Brull SJ, Kalsotra S. Pediatric Intraoperative Electromyographic Responses at the Adductor Pollicis and Flexor Hallucis Brevis Muscles: A Prospective, Comparative Analysis. Anesth Analg. 2024 Jul 1;139(1):36-43. doi: 10.1213/ANE.0000000000006926. Epub 2024 Jun 17.
PMID: 38885397DERIVED
Results Point of Contact
- Title
- Joseph D. Tobias, MD
- Organization
- Nationwide Children's Hospital
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Chairman, Dept. of Anesthesiology & Pain Medicine
Study Record Dates
First Submitted
July 13, 2020
First Posted
July 17, 2020
Study Start
February 1, 2021
Primary Completion
May 30, 2023
Study Completion
May 30, 2023
Last Updated
August 12, 2024
Results First Posted
August 12, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share